How to Ethically Commercialize Psychedelics? Challenges To Be Spotlighted at Horizons 2021 Conference in NYC

Billed as the “the largest and longest-running annual gathering of the psychedelic community in the world,” Horizons: Perspectives on Psychedelics, returns to Cooper Union in Manhattan  December 1-5. Parts of the program will be held at NY Academy of Medicine, underlining the field’s growing acceptance. For 2021, the Business Forum was co-developed by North Star PBC, a values-focused spinoff of Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS and its newly formed development arm, MAPS PBC, are hoping for a 2023 FDA approval of MDMA as treatment for Post-Traumatic Stress Disorder. The MAPS approach to “medicalization” has inspired a wave of startups and a nascent industry of psychedelic wellness clinics. A few of the startups have achieved successful IPOs (Compass, Atai).

MAPS speakers directly involved in the Phase IIIa studies for MDMA include:

Michael Mithoefer, Senior Medical DirectorRebecca Matthews, Chief Clinical Operations OfficerElizabeth Nielsen, Site Co-principal Investigator and Therapist

Other notable speakers include Matthew Johnson, PI on multiple clinical trials, and Professor at the Johns Hopkins Center for Psychedelics and Conscious...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee